,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,82806,370,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,155,1,1,,515619,370,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
2,157,1,1,,82806,370,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
3,157,1,1,,515619,370,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
4,161,1,1,,82806,370,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
5,161,1,1,,515619,370,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
6,165,1,1,,82806,370,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
7,165,1,1,,515619,370,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
8,167,1,1,,82806,370,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
9,167,1,1,,515619,370,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
10,175,1,1,,82806,370,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
11,175,1,1,,515619,370,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
12,179,1,1,,515619,370,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
13,228,1,1,,82806,370,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Friend Virus Leukemia (Solid) (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
14,270,1,1,,82806,370,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
15,328,1,1,,82806,370,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
16,330,1,1,,82806,370,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
17,421,1,3,,17389871,370,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
18,426,1,2,,17389871,370,Inactive,,,,,Cell Viability - Jurkat,Confirmatory,,
19,427,1,1,,17389871,370,Inconclusive,,,,,Cell Viability - Hek293,Confirmatory,,
20,433,1,1,,17389871,370,Inactive,,,,,Cell Viability - HepG2,Confirmatory,,
21,434,1,2,,17389871,370,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
22,435,1,2,,17389871,370,Inactive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
23,445,3,1,,17389871,370,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
24,530,1,1,,17389871,370,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
25,540,1,1,,17389871,370,Inactive,,,,,Cell Viability - N2a,Confirmatory,,
26,541,1,1,,17389871,370,Active,,,,,Cell Viability - NIH 3T3,Confirmatory,,
27,542,1,1,,17389871,370,Inactive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
28,543,1,1,,17389871,370,Inconclusive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
29,544,2,1,,17389871,370,Inconclusive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
30,545,1,1,,17389871,370,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
31,546,1,1,,17389871,370,Inconclusive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
32,584,1,3,,17389871,370,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
33,585,1,4,,17389871,370,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
34,595,1,3,,17389871,370,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
35,596,1,2,,17389871,370,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
36,603,1,2,,17389871,370,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
37,605,1,2,,17389871,370,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
38,608,1,6,,11537513,370,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
39,654,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
40,655,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
41,656,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
42,657,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
43,658,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
44,659,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
45,660,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
46,661,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
47,662,1,1,,17389871,370,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
48,663,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
49,664,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
50,665,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
51,666,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
52,667,1,1,,17389871,370,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
53,875,1,2,,17389871,370,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
54,880,2,1,,17389871,370,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
55,880,2,1,,17389871,370,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
56,880,2,1,,26747307,370,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
57,880,2,1,,26747307,370,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
58,881,2,2,,17389871,370,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
59,884,1,2,,17389871,370,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
60,885,1,2,,17389871,370,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
61,886,1,2,,17389871,370,Active,122921310.0,,0.0501,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
62,886,1,2,,17389871,370,Active,122921311.0,,0.0501,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
63,887,1,2,,17389871,370,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
64,889,1,3,,17389871,370,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
65,892,1,2,,17389871,370,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
66,893,1,2,,17389871,370,Active,122921310.0,,19.9526,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
67,893,1,2,,17389871,370,Active,122921311.0,,19.9526,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
68,894,2,1,,17389871,370,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
69,894,2,1,,26747307,370,Active,31542939.0,3248.0,7.0795,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
70,900,1,3,,17389871,370,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
71,902,1,2,,17389871,370,Active,120407068.0,7157.0,10.0,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
72,910,1,2,,17389871,370,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
73,912,1,2,,17389871,370,Inconclusive,21392848.0,,15.8489,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
74,921,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-001,Confirmatory,,
75,923,1,2,,17389871,370,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
76,924,1,2,,17389871,370,Active,120407068.0,7157.0,12.5893,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
77,925,1,2,,17389871,370,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
78,926,1,2,,17389871,370,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
79,927,1,3,,17389871,370,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
80,930,1,2,,17389871,370,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
81,938,1,2,,17389871,370,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
82,940,1,2,,26613118,370,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
83,946,1,2,,17389871,370,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
84,947,1,2,,17389871,370,Inconclusive,,,39.8107,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
85,948,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
86,955,1,2,,17389871,370,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
87,960,1,2,,17389871,370,Inconclusive,,,12.5893,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
88,961,1,2,,17389871,370,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
89,962,1,2,,17389871,370,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
90,963,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
91,964,1,2,,17389871,370,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
92,965,1,2,,17389871,370,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-003,Confirmatory,,
93,966,1,2,,17389871,370,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-004,Confirmatory,,
94,967,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-005,Confirmatory,,
95,968,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-009,Confirmatory,,
96,969,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-011,Confirmatory,,
97,970,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-013,Confirmatory,,
98,971,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-015,Confirmatory,,
99,972,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-017,Confirmatory,,
100,973,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-019,Confirmatory,,
101,974,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-021,Confirmatory,,
102,975,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-023,Confirmatory,,
103,976,1,2,,17389871,370,Inconclusive,,,31.6228,Potency,Cell Viability - LYMP2-025,Confirmatory,,
104,977,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-002,Confirmatory,,
105,978,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-006,Confirmatory,,
106,979,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-007,Confirmatory,,
107,980,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-008,Confirmatory,,
108,981,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-010,Confirmatory,,
109,982,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-012,Confirmatory,,
110,983,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-014,Confirmatory,,
111,984,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-016,Confirmatory,,
112,985,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-018,Confirmatory,,
113,986,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-020,Confirmatory,,
114,987,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-022,Confirmatory,,
115,988,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-024,Confirmatory,,
116,989,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP2-026,Confirmatory,,
117,993,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
118,994,1,2,,17389871,370,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
119,995,1,2,,17389871,370,Inconclusive,66932916.0,5594.0,25.1189,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
120,1030,2,1,,17389871,370,Active,30582681.0,216.0,8.9125,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
121,1030,2,1,,26747307,370,Active,30582681.0,216.0,1.9953,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
122,1033,2,2,,11537513,370,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
123,1189,1,5,,48413806,370,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
124,1194,1,3,,48413806,370,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
125,1208,1,3,,48413806,370,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
126,1379,1,2,,26747307,370,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
127,1422,1,1,,26613118,370,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
128,1452,1,1,,17389871,370,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
129,1454,1,1,,26747307,370,Inconclusive,66932916.0,5594.0,22.3872,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
130,1457,1,1,,17389871,370,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
131,1457,1,1,,26747307,370,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
132,1458,1,1,,17389871,370,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
133,1458,1,1,,26747307,370,Inactive,10937869.0,6607.0,15.8489,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
134,1460,1,3,,26747307,370,Active,92096784.0,4137.0,1.2589,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
135,1463,1,1,,26747307,370,Active,,,3.9811,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
136,1467,1,3,,26747307,370,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
137,1468,1,1,,26747307,370,Active,92096784.0,4137.0,1.9953,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
138,1469,1,1,,17389871,370,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
139,1469,1,1,,26747307,370,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
140,1471,2,1,,17389871,370,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
141,1471,2,1,,26747307,370,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
142,1476,2,1,,17389871,370,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
143,1476,2,1,,26747307,370,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
144,1477,1,1,,17389871,370,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
145,1477,1,1,,26747307,370,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
146,1478,2,1,,17389871,370,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
147,1478,2,1,,26747307,370,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
148,1479,1,2,,17389871,370,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
149,1479,1,2,,26747307,370,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
150,1487,1,1,,17389871,370,Inconclusive,27436948.0,4000.0,0.2818,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
151,1490,2,1,,17389871,370,Active,10954339.0,,8.9125,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
152,1490,2,1,,26747307,370,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
153,1519,1,3,,26747307,370,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
154,1549,1,2,,11537513,370,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
155,1552,1,3,,11537513,370,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
156,1637,1,2,,11537513,370,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
157,1648,1,2,,11537513,370,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
158,1688,1,1,,17389871,370,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
159,1766,1,1,,17389871,370,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
160,1766,1,1,,17389871,370,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
161,1766,1,1,,26747307,370,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
162,1766,1,1,,26747307,370,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
163,1768,1,1,,17389871,370,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
164,1768,1,1,,17389871,370,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
165,1768,1,1,,26747307,370,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
166,1768,1,1,,26747307,370,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
167,1865,1,1,,26747307,370,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
168,1948,1,1,,17389871,370,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
169,1948,1,1,,26747307,370,Inactive,,,10.0,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
170,2101,1,1,,17389871,370,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
171,2101,1,1,,26747307,370,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
172,2107,1,1,,17389871,370,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
173,2107,1,1,,26747307,370,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
174,2112,1,1,,17389871,370,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
175,2112,1,1,,26747307,370,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
176,2120,1,1,,17389871,370,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
177,2147,1,1,,26747307,370,Active,221046486.0,,0.3548,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
178,2451,1,2,,26747307,370,Active,122920737.0,,3.5397,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
179,2472,1,2,,26747307,370,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
180,2517,2,1,,17389871,370,Inconclusive,6980812.0,,31.6228,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
181,2517,2,1,,26747307,370,Inconclusive,6980812.0,,0.631,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
182,2528,1,2,,17389871,370,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
183,2528,1,2,,26747307,370,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
184,2546,1,1,,17389871,370,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
185,2546,1,1,,26747307,370,Inconclusive,188536040.0,19885.0,17.7828,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
186,2549,1,1,,17389871,370,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
187,2549,1,1,,26747307,370,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
188,2551,1,1,,17389871,370,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
189,2551,1,1,,26747307,370,Active,188536040.0,19885.0,10.0,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
190,2662,2,1,,17389871,370,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
191,2785,1,1,,26747307,370,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Giardia lamblia growth inhibition",Confirmatory,,
192,2786,1,1,,26747307,370,Active,,,39.8107,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Mammalian cellular toxicity",Confirmatory,,
193,2787,1,1,,26747307,370,Active,122920737.0,,14.1254,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Primary screen confirmation",Confirmatory,,
194,2794,1,1,,26747307,370,Active,126722869.0,100009055.0,19.9526,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Rabbit FBPA Selectivity",Confirmatory,,
195,2795,1,1,,26747307,370,Active,7669492.0,2597.0,25.1189,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen confirmation",Confirmatory,,
196,83434,8,4,,103217472,370,Inconclusive,,,,,Inhibitory concentration against polymerization in A17 double mutant HIV-1 RT using a template primer of poly rC/dG12-18 and [3H]dGTP; ND is not determined,Other,11591519.0,
197,83435,9,5,,103217472,370,Unspecified,82310930.0,,100.0,IC50,Inhibition of polymerization in wild type HIV-1 RT with poly rC/dG12-18 template primer and [3H]dGTP,Confirmatory,11591519.0,
198,86649,3,5,,103217472,370,Unspecified,,,,,Percent reduction in cell viability of HeLa cells 72 hr after incubation with compound,Other,14640548.0,
199,101828,3,5,,103217472,370,Unspecified,,,,,Percent reduction in cell viability of MDA-MB-231 cells 72 hr after incubation with compound,Other,14640548.0,
200,105091,3,5,,103217472,370,Unspecified,,,,,Percent reduction in cell viability of MOLT-3 cells 72 hr after incubation with the compound,Other,14640548.0,
201,132501,6,2,,103217472,370,Unspecified,,,63.0,IC50,Inhibitory activity against nitric oxide production in LPS-activated mouse peritoneal macrophages,Confirmatory,10714491.0,
202,228902,8,1,,103217472,370,Active,,,14.3,ED50,"Effective dose required for antioxidant activity was measured as dose giving 50% decolorization of 2,2-diphenyl-1-picryl-hydrazyl (DPPH)",Confirmatory,12039563.0,
203,232817,3,3,,103217472,370,Unspecified,,,,,The degree of collagen cross-linking by hydrothermal shrinkage temperature was determined,Other,12039563.0,
204,264487,3,4,,103217472,370,Unspecified,,,,,[1-3H]-2-deoxy-D-glucose uptake in 3T3 L1 adipocytes,Other,16640344.0,
205,269889,6,2,,103217472,370,Active,,,6.0,IC50,DPPH radical scavenging activity in ethanol solution,Confirmatory,16713262.0,
206,269890,6,2,,103217472,370,Active,,,7.3,IC50,DPPH radical scavenging activity in liposome,Confirmatory,16713262.0,
207,280289,9,5,,103217472,370,Unspecified,126180.0,6401.0,500.0,IC50,Inhibition of human E-selectin after 2 hrs,Confirmatory,17302397.0,
208,280291,9,5,,103217472,370,Active,215274139.0,6403.0,19.1,IC50,Inhibition of human P-selectin after 2 hrs,Confirmatory,17302397.0,
209,280293,9,5,,103217472,370,Active,126178.0,6402.0,27.6,IC50,Inhibition of human L-selectin after 2 hrs,Confirmatory,17302397.0,
210,311580,7,1,,103217472,370,Active,,,,,Antioxidant activity assessed as DPPH radical scavenging activity,Other,17907781.0,
211,311581,6,2,,103217472,370,Active,,,0.53,IC50,Antioxidant activity assessed as superoxide anion radical scavenging activity,Confirmatory,17907781.0,
212,314588,7,6,,103217472,370,Unspecified,21431789.0,,50.0,IC50,Antagonist activity at LuxP receptor in Vibrio harveyi MM32 assessed as inhibition of autoinducer-2-mediated quorum sensing after 3 to 4 hrs,Confirmatory,18262415.0,
213,314590,3,3,,103217472,370,Inactive,,,,,Growth inhibition of Vibrio harveyi assessed as time required to double bacterial growth relative to control,Other,18262415.0,
214,315606,3,4,,103217472,370,Unspecified,,,,,Growth inhibition of human BGC823 cells at 5 uM after 72 hrs by MTT assay relative to control,Other,17997321.0,
215,315607,3,4,,103217472,370,Unspecified,,,,,Growth inhibition of human BGC823 cells at 10 uM after 72 hrs by MTT assay relative to control,Other,17997321.0,
216,315608,3,4,,103217472,370,Unspecified,,,,,Growth inhibition of human BGC823 cells at 50 uM after 72 hrs by MTT assay relative to control,Other,17997321.0,
217,315609,3,4,,103217472,370,Unspecified,,,,,Growth inhibition of human BGC823 cells at 100 uM after 72 hrs by MTT assay relative to control,Other,17997321.0,
218,336478,3,7,,103217472,370,Unspecified,,,,,Inhibition of COX2 at 100 uM by scintillation proximity assay,Other,12444669.0,
219,337227,6,3,,103217472,370,Active,,,19.0,IC50,Antialgal activity against Microcystis aeruginosa NIES 44 after 24 hrs by fluorophotometric method,Confirmatory,,
220,337228,6,3,,103217472,370,Active,,,33.0,IC50,Antialgal activity against Anabaena flos-aquae NIES 73 after 48 hrs by fluorophotometric method,Confirmatory,,
221,338980,12,1,,103217472,370,Unspecified,,,7700.0,IC50,Inhibition of ACE by fluorometric assay,Confirmatory,3379417.0,
222,339009,5,1,,103217472,370,Unspecified,,,,,Cytotoxicity against mouse P388 cells,Other,3404159.0,
223,344828,5,4,,103217472,370,Unspecified,,,,,Inhibition of NADPH oxidase in LPS-induced mouse BV2 cells assessed as NOX-dependent ROS production at 50 uM,Other,18926710.0,
224,344829,9,5,,103217472,370,Unspecified,266649.0,18126.0,50.0,IC50,Inhibition of iNOS-mediated NO production in LPS-induced mouse BV2 cells,Confirmatory,18926710.0,
225,344830,3,4,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 50 uM,Other,18926710.0,
226,355135,6,2,,103217472,370,Unspecified,,,,,Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 by disk diffusion method,Other,8904847.0,
227,355136,6,2,,103217472,370,Unspecified,,,,,Antimicrobial activity against Prevotella intermedia by disk diffusion method,Other,8904847.0,
228,355137,6,2,,103217472,370,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans Ingbritt by disk diffusion method,Other,8904847.0,
229,355138,6,2,,103217472,370,Unspecified,,,,,Antimicrobial activity against Actinomyces viscosus W1053 by disk diffusion method,Other,8904847.0,
230,357307,9,5,,103217472,370,Unspecified,1706689.0,29230.0,73.0,IC50,Inhibition of C-terminal hexahistidine-tagged rat recombinant squalene epoxidase without N-terminal putative membrane domain expressed in Escherichia coli,Confirmatory,11520216.0,
231,357365,6,3,,103217472,370,Active,,,17.6,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins,Confirmatory,11520237.0,
232,360324,8,2,,103217472,370,Unspecified,,,,,"Antiplasmodial activity after 24 hrs against chloroquine-sensitive, mefloquine-resistant Plasmodium falciparum D6 infected human erythrocytes by [G-3H]hypoxanthine uptake",Other,11374952.0,
233,377793,6,2,,103217472,370,Unspecified,,,,,Antibabesial activity against Babesia gibsoni in dog erythrocytes after 72 hrs,Other,15844943.0,
234,377794,6,2,,103217472,370,Unspecified,,,,,Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCR3 in human erythrocytes after 24 hrs,Other,15844943.0,
235,377795,3,3,,103217472,370,Unspecified,,,,,Cytotoxicity against dog RBC,Other,15844943.0,
236,377796,3,3,,103217472,370,Unspecified,,,,,Cytotoxicity against human RBC,Other,15844943.0,
237,377830,6,3,,103217472,370,Active,,,2.7,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Confirmatory,15844957.0,
238,377909,6,3,,103217472,370,Active,,,4.2,EC50,Antioxidant activity assessed as DPPH free radical scavenging activity,Confirmatory,11076575.0,
239,378648,6,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Other,11141121.0,
240,378878,6,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity,Other,10650074.0,
241,378879,6,2,,103217472,370,Unspecified,,,,,Antioxidant activity in human HL60 cells assessed as reduction of cytochrome-c release,Other,10650074.0,
242,380094,6,3,,103217472,370,Active,,,29.9,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity,Confirmatory,16562825.0,
243,380372,3,3,,103217472,370,Unspecified,,,,,DPPH radical scavenging activity at 80 uM after 30 mins by spectrophotometric assay,Other,10869193.0,
244,380373,3,3,,103217472,370,Unspecified,,,,,DPPH radical scavenging activity at 40 uM after 30 mins by spectrophotometric assay,Other,10869193.0,
245,380374,3,3,,103217472,370,Unspecified,,,,,DPPH radical scavenging activity at 20 uM after 30 mins by spectrophotometric assay,Other,10869193.0,
246,380375,3,3,,103217472,370,Unspecified,,,,,DPPH radical scavenging activity at 10 uM after 30 mins by spectrophotometric assay,Other,10869193.0,
247,380376,3,3,,103217472,370,Unspecified,,,,,DPPH radical scavenging activity at 5 uM after 30 mins by spectrophotometric assay,Other,10869193.0,
248,380377,3,3,,103217472,370,Unspecified,,,,,DPPH radical scavenging activity at 2.5 uM after 30 mins by spectrophotometric assay,Other,10869193.0,
249,381917,6,2,,103217472,370,Unspecified,,,50.0,IC50,Cytotoxicity against mouse L1210 cells after 48 hrs by MTT assay,Confirmatory,18295493.0,
250,381918,6,2,,103217472,370,Unspecified,,,50.0,IC50,Cytotoxicity against mouse L1210 cells after 72 hrs by MTT assay,Confirmatory,18295493.0,
251,381919,6,2,,103217472,370,Unspecified,,,50.0,IC50,Cytotoxicity against human CEM cells after 24 hrs by MTT assay,Confirmatory,18295493.0,
252,381920,6,2,,103217472,370,Unspecified,,,50.0,IC50,Cytotoxicity against human CEM cells after 72 hrs by MTT assay,Confirmatory,18295493.0,
253,381922,3,4,,103217472,370,Active,,,,,Decrease in mitochondrial glutathione level in mouse L1210 cells,Other,18295493.0,
254,381923,3,4,,103217472,370,Unspecified,,,,,Decrease in cytoplasmic glutathione level in mouse L1210 cells at 100 uM,Other,18295493.0,
255,381924,6,2,,103217472,370,Unspecified,,,299.0,IC50,Genotoxicity against african green monkey VERO cells,Confirmatory,18295493.0,
256,381925,3,4,,103217472,370,Active,,,,,Decrease in cytoplasmic glutathione level in mouse L1210 cells,Other,18295493.0,
257,381926,6,2,,103217472,370,Unspecified,,,1.0,IC50,Cytotoxicity against african green monkey VERO cells,Confirmatory,18295493.0,
258,381927,3,4,,103217472,370,Active,,,,,Induction of apoptosis in mouse L1210 cells assessed as internucleosomal breakdown of DNA chromatin at 30 uM,Other,18295493.0,
259,381928,3,4,,103217472,370,Active,,,,,Induction of apoptosis in human CEM cells assessed as internucleosomal breakdown of DNA chromatin at 30 uM,Other,18295493.0,
260,381929,3,4,,103217472,370,Active,,,,,Induction of apoptosis in mouse L1210 cells assessed as internucleosomal breakdown of DNA chromatin at 100 uM,Other,18295493.0,
261,381930,3,4,,103217472,370,Active,,,,,Induction of apoptosis in human CEM cells assessed as internucleosomal breakdown of DNA chromatin at 100 uM,Other,18295493.0,
262,382837,6,2,,103217472,370,Active,,,8.0,IC50,DPPH radical scavenging activity after 180 mins,Confirmatory,18314960.0,
263,385427,3,3,,103217472,370,Unspecified,,,,,Inhibition of soybean 15-lipoxygenase,Other,18314336.0,
264,388742,12,2,,103217472,370,Unspecified,113596.0,231.0,,IC50,Inhibition of cataracted human eye lens aldose reductase,Confirmatory,18976928.0,
265,388743,6,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins,Other,18976928.0,
266,395150,9,1,,103217472,370,Unspecified,,,,,ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity,Other,18403057.0,
267,397104,3,4,,103217472,370,Inactive,,,,,Inhibition of Rauscher murine leukemia virus reverse transcriptase assessed as incorporation of [3H]dTMP at 10 ug/ml,Other,1705574.0,
268,397105,3,4,,103217472,370,Inactive,,,,,Inhibition of HIV reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTMP at 10 ug/ml,Other,1705574.0,
269,397116,3,4,,103217472,370,Inactive,,,,,Inhibition of HIV reverse transcriptase activity expressed in Escherichia coli,Other,1705574.0,
270,397117,3,4,,103217472,370,Inactive,,,,,Inhibition of Rauscher murine leukemia virus reverse transcriptase activity,Other,1705574.0,
271,397155,8,1,,103217472,370,Unspecified,,,,,Antioxidant activity against Cu2+-induced lipid peroxidation in human plasma LDL at 0.2 umol/L preincubated for 1 hr before Cu2+ challenge,Other,11325231.0,
272,397156,8,1,,103217472,370,Unspecified,,,,,Antioxidant activity against Cu2+-induced lipid peroxidation in human plasma LDL at 1 umol/L preincubated for 1 hr before Cu2+ challenge,Other,11325231.0,
273,397157,8,1,,103217472,370,Unspecified,,,,,Antioxidant activity against AAPH-induced lipid peroxidation in human plasma LDL at 0.2 umol/L preincubated for 1 hr before AAPH challenge,Other,11325231.0,
274,397158,8,1,,103217472,370,Unspecified,,,,,Antioxidant activity against AAPH-induced lipid peroxidation in human plasma LDL at 1 umol/L preincubated for 1 hr before AAPH challenge,Other,11325231.0,
275,397159,3,3,,103217472,370,Active,,,,,Antioxidant activity against Cu2+-induced lipid peroxidation in human plasma LDL at 0.01 to 0.1 umol/L preincubated for 1 hr before Cu2+ challenge,Other,11325231.0,
276,397160,3,3,,103217472,370,Active,,,,,Antioxidant activity against AAPH-induced lipid peroxidation in human plasma LDL at 0.01 to 0.1 umol/L preincubated for 1 hr before AAPH challenge,Other,11325231.0,
277,397586,3,9,,103217472,370,Unspecified,2497687.0,7941.0,,,Effect on human plasma LDL-PLA2 activity by LS-3B fluorescence spectrometry,Other,11325231.0,
278,397831,4,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins by UV-visible spectrophotometry,Other,12502312.0,
279,400503,3,4,,103217472,370,Active,,,,,Antibacterial activity against Bacillus sphaericus by test disc paper method,Other,,
280,400505,2,4,,103217472,370,Unspecified,,,,,Antibacterial activity against Bacillus subtilis at 100 ug by test disc paper method,Other,,
281,400506,3,1,,103217472,370,Unspecified,,,,,Growth inhibition of tobacco budworm larvae assessed as percent of diet,Other,,
282,400984,3,4,,103217472,370,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 0.1 uM,Other,2413172.0,
283,400985,3,4,,103217472,370,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 1 uM,Other,2413172.0,
284,400986,3,4,,103217472,370,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 10 uM,Other,2413172.0,
285,400987,3,4,,103217472,370,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 100 uM,Other,2413172.0,
286,400988,3,4,,103217472,370,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 1000 uM,Other,2413172.0,
287,400989,3,4,,103217472,370,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 0.1 uM,Other,2413172.0,
288,400990,3,4,,103217472,370,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 1 uM,Other,2413172.0,
289,400991,3,4,,103217472,370,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 10 uM,Other,2413172.0,
290,400992,3,4,,103217472,370,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 100 uM,Other,2413172.0,
291,400993,3,4,,103217472,370,Unspecified,,,,,Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 1000 uM,Other,2413172.0,
292,401061,6,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity,Other,9599286.0,
293,401336,6,2,,103217472,370,Active,,,1.01,IC50,Antioxidant activity assessed by superoxide anion scavenging assay,Confirmatory,8991956.0,
294,401337,6,2,,103217472,370,Unspecified,,,78.0,IC50,Antioxidant activity assessed by hydroxyl radical scavenging assay,Confirmatory,8991956.0,
295,401338,6,2,,103217472,370,Unspecified,,,69.8,IC50,Antioxidant activity assessed by singlet oxygen scavenging assay,Confirmatory,8991956.0,
296,417959,6,2,,103217472,370,Unspecified,,,,,Antifungal activity against Candida albicans after 48 hrs by broth microdilution technique,Other,19232493.0,
297,417960,6,2,,103217472,370,Unspecified,,,,,Antifungal activity against Candida tropicalis after 48 hrs by broth microdilution technique,Other,19232493.0,
298,417961,6,2,,103217472,370,Unspecified,,,,,Antifungal activity against Saccharomyces cerevisiae after 48 hrs by broth microdilution technique,Other,19232493.0,
299,417962,6,2,,103217472,370,Unspecified,,,,,Antifungal activity against Cryptococcus neoformans after 48 hrs by broth microdilution technique,Other,19232493.0,
300,417963,6,2,,103217472,370,Unspecified,,,,,Antimicrobial activity against Aspergillus fumigatus after 48 hrs by broth microdilution technique,Other,19232493.0,
301,417964,6,2,,103217472,370,Unspecified,,,,,Antimicrobial activity against Aspergillus flavus after 48 hrs by broth microdilution technique,Other,19232493.0,
302,417965,6,2,,103217472,370,Unspecified,,,,,Antimicrobial activity against Aspergillus niger after 48 hrs by broth microdilution technique,Other,19232493.0,
303,417966,6,2,,103217472,370,Unspecified,,,,,Antimicrobial activity against Microsporum gypseum after 48 hrs by broth microdilution technique,Other,19232493.0,
304,417967,7,2,,103217472,370,Unspecified,,,,,Antimicrobial activity against Epidermophyton floccosum after 48 hrs by broth microdilution technique,Other,19232493.0,
305,417968,6,2,,103217472,370,Unspecified,,,,,Antimicrobial activity against Trichophyton rubrum after 48 hrs by broth microdilution technique,Other,19232493.0,
306,417969,6,2,,103217472,370,Unspecified,,,,,Antimicrobial activity against Trichophyton mentagrophytes after 48 hrs by broth microdilution technique,Other,19232493.0,
307,436175,3,5,,103217472,370,Unspecified,,,,,Antiinflammatory activity in human neutrophils assessed as respiratory burst inhibition at 1000 ug/ml by WST-1 assay,Other,19006373.0,
308,437510,9,2,,103217472,370,Inactive,,,,IC50,Inhibition of MET kinase,Confirmatory,19839593.0,
309,448520,4,2,,103217472,370,Unspecified,,,,,Toxicity against Artemia salina assessed as number of the nauplii died after 24 hrs,Other,19586688.0,
310,462270,8,5,,103217472,370,Active,115449.0,759.0,3.2,Ki,Inhibition of human CA1 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
311,462271,8,5,,103217472,370,Active,115456.0,760.0,2.25,Ki,Inhibition of human CA2 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
312,462272,8,5,,103217472,370,Active,134047703.0,761.0,7.49,Ki,Inhibition of human CA3 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
313,462273,8,5,,103217472,370,Active,115465.0,762.0,9.8,Ki,Inhibition of human CA4 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
314,462274,8,5,,103217472,370,Active,461680.0,763.0,4.08,Ki,Inhibition of human CA5A by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
315,462275,8,5,,103217472,370,Active,8928041.0,11238.0,9.97,Ki,Inhibition of human CA5B by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
316,462276,8,5,,103217472,370,Active,116241278.0,765.0,6.13,Ki,Inhibition of human CA6 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
317,462277,8,5,,103217472,370,Active,1168744.0,766.0,6.07,Ki,Inhibition of human CA7 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
318,462278,8,5,,103217472,370,Active,83300925.0,768.0,6.99,Ki,Inhibition of human CA9 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
319,462279,8,5,,103217472,370,Active,5915866.0,771.0,7.78,Ki,Inhibition of human CA12 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
320,462280,8,5,,103217472,370,Active,30580372.0,71934.0,9.86,Ki,Inhibition of mouse CA13 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
321,462281,8,5,,103217472,370,Active,8928036.0,23632.0,7.03,Ki,Inhibition of human CA14 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
322,475023,3,4,,103217472,370,Inconclusive,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 1 mM after 20 mins by spectrophotometry,Other,20207143.0,
323,475260,3,4,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 1 uM after 2 mins by spectrophotometry,Other,20207143.0,
324,475261,3,4,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 1 uM after 4 mins by spectrophotometry,Other,20207143.0,
325,475262,3,4,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 1 uM after 6 mins by spectrophotometry,Other,20207143.0,
326,475263,3,4,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 1 uM after 8 mins by spectrophotometry,Other,20207143.0,
327,475264,3,4,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 1 uM after 10 mins by spectrophotometry,Other,20207143.0,
328,485281,1,1,,26747307,370,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
329,485290,1,1,,17389871,370,Inconclusive,20150581.0,,1.0,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
330,485290,1,1,,26747307,370,Inconclusive,20150581.0,,2.5119,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
331,485350,1,2,,92124939,370,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
332,486890,4,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Other,20499922.0,
333,486891,4,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 2 hrs,Other,20499922.0,
334,486892,4,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 8 hrs,Other,20499922.0,
335,489007,1,1,,26747307,370,Inconclusive,20150581.0,,31.6228,Potency,Confirmation Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
336,492961,1,1,,17389871,370,Inconclusive,72386991.0,3656265.0,31.6228,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
337,493033,1,2,,92124939,370,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
338,501209,7,1,,103217472,370,Inactive,,,,IC50,Antiviral activity against HSV1 infected african green monkey Vero cells assessed as reduction of plaque formation after 3 days by using crystal violet stain,Confirmatory,20092288.0,
339,501210,2,4,,103217472,370,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells after 3 days by MTT assay,Other,20092288.0,
340,504327,1,1,,17389871,370,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
341,504327,1,1,,26747307,370,Inconclusive,153791535.0,2648.0,39.8107,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
342,504332,1,1,,17389871,370,Active,168985070.0,,1.9953,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
343,504332,1,1,,26747307,370,Inconclusive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
344,504749,1,3,,17389871,370,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
345,504749,1,3,1.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
346,504749,1,3,2.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
347,504749,1,3,3.0,17389871,370,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
348,504749,1,3,4.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
349,504749,1,3,5.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
350,504749,1,3,6.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
351,504749,1,3,7.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
352,504749,1,3,8.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
353,504749,1,3,9.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
354,504749,1,3,10.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
355,504749,1,3,11.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
356,504749,1,3,12.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
357,504749,1,3,13.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
358,504749,1,3,14.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
359,504749,1,3,15.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
360,504749,1,3,16.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
361,504749,1,3,17.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
362,504749,1,3,18.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
363,504749,1,3,19.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
364,504749,1,3,20.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
365,504749,1,3,21.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
366,504749,1,3,22.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
367,504749,1,3,23.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
368,504749,1,3,24.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
369,504749,1,3,25.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
370,504749,1,3,26.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
371,504749,1,3,27.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
372,504749,1,3,28.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
373,504749,1,3,29.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
374,504749,1,3,30.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
375,504749,1,3,31.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
376,504749,1,3,32.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
377,504749,1,3,33.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
378,504749,1,3,34.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
379,504749,1,3,35.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
380,504749,1,3,36.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
381,504749,1,3,37.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
382,504749,1,3,38.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
383,504749,1,3,39.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
384,504749,1,3,40.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
385,504749,1,3,41.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
386,504749,1,3,42.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
387,504749,1,3,43.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
388,504749,1,3,44.0,17389871,370,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
389,504749,1,3,45.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
390,504749,1,3,46.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
391,504749,1,3,47.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
392,504749,1,3,48.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
393,504749,1,3,49.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
394,504749,1,3,50.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
395,504749,1,3,51.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
396,504749,1,3,52.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
397,504749,1,3,53.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
398,504749,1,3,54.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
399,504749,1,3,55.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
400,504749,1,3,56.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
401,504749,1,3,57.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
402,504749,1,3,58.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
403,504749,1,3,59.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
404,504749,1,3,60.0,17389871,370,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
405,504749,1,3,61.0,17389871,370,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
406,504770,1,2,,92124939,370,Inactive,9657380.0,2612528.0,,,A screen for compounds that inhibit replication of Vibrio cholerae chromosome II,Other,,
407,504832,1,1,,17389871,370,Inconclusive,,,16.9441,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
408,504834,1,1,,17389871,370,Active,,,8.4921,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
409,504847,1,1,,17389871,370,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
410,504847,1,1,,26747307,370,Active,63054845.0,7421.0,50.1187,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
411,504865,1,1,,17389871,370,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
412,504865,1,1,,26747307,370,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
413,536046,1,4,,103217472,370,Unspecified,,,,,Antioxidant activity against ABTS radical assessed as Trolox equivalent,Other,20965736.0,
414,536052,1,5,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity by measuring [DPPH]/antioxidant EC50 ratio measured every 5 mins for 1 hr,Other,20965736.0,
415,540299,1,2,,92124939,370,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
416,548181,4,3,,103217472,370,Active,,,33.92,IC50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,21028890.0,
417,548182,4,2,,103217472,370,Active,,,19.76,IC50,Antioxidant activity assessed as ABTS radical scavenging activity,Confirmatory,21028890.0,
418,555340,2,3,,103217472,370,Unspecified,,,,,Effect on growth in Staphylococcus aureus MN8 at 0.50 % after 24 hrs (Rvb = 100%),Other,19223628.0,
419,555341,2,3,,103217472,370,Unspecified,,,,,Effect on growth in Staphylococcus aureus MN8 at 0.10 % after 24 hrs (Rvb = 100%),Other,19223628.0,
420,555372,3,3,,103217472,370,Unspecified,,,,,Induction of toxin TSST-1 production in Staphylococcus aureus MN8 at 0.50 % after 24 hrs relative to control,Other,19223628.0,
421,555373,2,3,,103217472,370,Unspecified,,,,,Induction of toxin TSST-1 production in Staphylococcus aureus MN8 at 0.10 % after 24 hrs relative to control,Other,19223628.0,
422,588513,1,1,,17389871,370,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
423,588514,1,1,,17389871,370,Inconclusive,348019627.0,2099.0,22.3872,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
424,588515,1,1,,17389871,370,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
425,588516,1,1,,17389871,370,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
426,588519,1,2,,92124939,370,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
427,588526,1,1,,17389871,370,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
428,588527,1,1,,17389871,370,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
429,588532,1,1,,17389871,370,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
430,588533,1,1,,17389871,370,Inconclusive,311348376.0,2908.0,22.3872,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
431,588534,1,1,,17389871,370,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
432,588535,1,1,,17389871,370,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
433,588536,1,1,,17389871,370,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
434,588537,1,1,,17389871,370,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
435,588541,1,1,,17389871,370,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
436,588543,1,1,,17389871,370,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
437,588544,1,1,,17389871,370,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
438,588545,1,1,,17389871,370,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
439,588546,1,1,,17389871,370,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
440,588547,1,1,,17389871,370,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
441,588579,1,1,,17389871,370,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
442,588579,1,1,,26747307,370,Active,7705344.0,51426.0,10.0,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
443,588834,2,1,,17389871,370,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
444,588834,2,1,,144204640,370,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
445,602314,1,2,,92124939,370,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
446,602332,1,1,,17389871,370,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
447,602332,1,1,,26747307,370,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
448,607497,6,5,,103217472,370,Active,123910379.0,,4.13,Ki,Inhibition of Dicentrarchus labrax CA using 4-nitrophenylacetate substrate by esterase assay,Confirmatory,21669522.0,
449,614098,4,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometric analysisic analysis,Other,21813280.0,
450,614099,1,4,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as H2O2 scavenging activity at 12.5 to 250 ug/mL after 30 mins by spectrophotometric analysisic analysis,Other,21813280.0,
451,614100,2,3,,103217472,370,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus ATCC 9144 after 24 hrs using thiazoyl blue by agar overlay bioautography method,Other,21813280.0,
452,614101,2,3,,103217472,370,Unspecified,,,,,Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs using thiazoyl blue by agar overlay bioautography method,Other,21813280.0,
453,614102,2,3,,103217472,370,Unspecified,,,,,Antimicrobial activity against Pseudomonas aeruginosa NCTC 10332 after 24 hrs using thiazoyl blue by agar overlay bioautography method,Other,21813280.0,
454,614103,2,3,,103217472,370,Unspecified,,,,,Antimicrobial activity against Candida albicans ATCC 10231 after 24 hrs using thiazoyl blue by agar overlay bioautography method,Other,21813280.0,
455,614104,2,3,,103217472,370,Unspecified,,,,,Antimicrobial activity against Escherichia coli ATCC 11229 after 24 hrs using thiazoyl blue by agar overlay bioautography method,Other,21813280.0,
456,616482,2,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity,Other,21821414.0,
457,624030,1,2,,17389871,370,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
458,624031,1,2,,17389871,370,Inconclusive,,,36.1254,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
459,624032,1,2,,17389871,370,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
460,624044,1,2,,17389871,370,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
461,624170,1,1,,17389871,370,Active,71051501.0,2744.0,10.0,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
462,624172,1,1,,17389871,370,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
463,624173,1,3,,17389871,370,Inconclusive,62359610.0,,12.5893,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
464,624296,1,1,,17389871,370,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
465,624297,1,1,,17389871,370,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
466,624349,1,2,,92307197,370,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
467,624606,1,9,,103217472,370,Unspecified,136729.0,54658.0,,,Specific activity of expressed human recombinant UGT1A1,Other,10836148.0,
468,638442,3,2,,103217472,370,Inactive,,,,IC50,Inhibition of yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 10 mins before substrate addition measured after 5 mins by micro-plate reader analysis,Confirmatory,22079755.0,
469,638443,3,3,,103217472,370,Active,,,20.39,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins,Confirmatory,22079755.0,
470,642414,1,9,,103217472,370,Unspecified,544257.0,2099.0,,,Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,Other,22137340.0,
471,642415,1,9,,103217472,370,Unspecified,544257.0,2099.0,,,Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,Other,22137340.0,
472,651631,4,1,,144204640,370,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
473,651631,4,1,,144209713,370,Inconclusive,269849759.0,7157.0,5.4982,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
474,651632,4,1,,144204640,370,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
475,651632,4,1,,144209713,370,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
476,651633,4,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
477,651633,4,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
478,651634,4,1,,144204640,370,Inconclusive,,,26.6032,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
479,651634,4,1,,144209713,370,Inconclusive,,,69.2179,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
480,651741,1,1,,17389871,370,Active,20149576.0,4780.0,4.2163,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
481,651743,1,1,,17389871,370,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
482,651749,1,1,,17389871,370,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
483,651751,1,1,,17389871,370,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
484,651754,1,1,,17389871,370,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
485,651755,1,1,,17389871,370,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
486,651757,1,1,,17389871,370,Inconclusive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
487,651758,1,1,,17389871,370,Inconclusive,186368.0,3576.0,47.3079,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
488,651777,1,1,,17389871,370,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
489,651778,1,1,,17389871,370,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
490,651802,1,1,,17389871,370,Inactive,49066040.0,6097.0,,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
491,651838,1,1,,17389871,370,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
492,651838,1,1,1.0,17389871,370,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
493,651838,1,1,2.0,17389871,370,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
494,651838,1,1,3.0,17389871,370,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
495,651838,1,1,4.0,17389871,370,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
496,651838,1,1,5.0,17389871,370,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
497,651838,1,1,6.0,17389871,370,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
498,651838,1,1,7.0,17389871,370,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
499,651838,1,1,8.0,17389871,370,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
500,652048,1,2,,144204640,370,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
501,652051,1,1,,144204640,370,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
502,671761,1,2,,103217472,370,Inactive,,,,,Inhibition of SARS coronavirus nsP13 helicase activity expressed in Escherichia coli Rosetta assessed inhibition of DNA unwinding activity at 10 uM by FRET assay,Other,22578462.0,
503,671762,1,2,,103217472,370,Inactive,,,,,Inhibition of HCV NS3 helicase overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of DNA unwinding activity at 10 uM by FRET assay,Other,22578462.0,
504,671764,1,2,,103217472,370,Inactive,,,,,Inhibition of HCV NS3 helicase ATP hydrolysis activity overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of inorganic phosphate release by AM/MG-based colometric analysis in the presence of M13 ssDNA,Other,22578462.0,
505,686978,1,1,,26747307,370,Active,79154014.0,55775.0,0.92,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
506,686978,1,1,,144204640,370,Inconclusive,79154014.0,55775.0,29.8554,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
507,686979,1,1,,26747307,370,Active,79154014.0,55775.0,0.5805,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
508,686979,1,1,,144204640,370,Inconclusive,79154014.0,55775.0,26.6086,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
509,689851,2,2,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as superoxide dismutase-like activity by SOD-WST assay,Other,23066712.0,
510,691434,3,5,,103217472,370,Unspecified,6686288.0,100157809.0,1000.0,IC50,Inhibition of porcine pancreatic lipase using micellar solution of triolein as substrate preincubated for 5 mins before substrate addition measured after 30 mins,Confirmatory,22995617.0,
511,691435,1,7,,103217472,370,Unspecified,6686288.0,100157809.0,,,Inhibition of porcine pancreatic lipase using micellar solution of triolein as substrate at 1 mM preincubated for 5 mins before substrate addition measured after 30 mins,Other,22995617.0,
512,707113,2,2,,103217472,370,Unspecified,,,631.6,IC50,Inhibition of LPS-induced NO production in mouse RAW264.7 cells assessed as reduction in nitrite level within 24 hrs by Griess reagent method,Confirmatory,22560043.0,
513,710229,1,2,,103217472,370,Inconclusive,,,,,Antioxidant activity of the compound assessed as DHR radical scavenging activity at 10 uM by fluorescence assay,Other,23151013.0,
514,710230,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity of the compound assessed as DPPH radical scavenging at 10 uM after 30 secs by spectrophotometry,Other,23151013.0,
515,710231,2,3,,103217472,370,Inconclusive,,,,IC50,Antioxidant activity assessed as scavenging of morpholino sydononimine based nitric oxide release by chemiluminescence assay,Confirmatory,23151013.0,
516,710235,2,2,,103217472,370,Inconclusive,,,,IC50,Antioxidant activity assessed as scavenging of glucose oxidase-generated H2O2 and hydroxyl radicals by chemiluminescence assay,Confirmatory,23151013.0,
517,711595,1,2,,103217472,370,Inactive,,,,,Increase of lifespan of Caenorhabditis elegans assessed as ascorbic acid equivalent of water soluble antioxidant metabolites at 300 uM by photochemiluminescence assay,Other,21805983.0,
518,711596,1,2,,103217472,370,Inactive,,,,,Increase of lifespan of Caenorhabditis elegans assessed as trolox equivalent of lipid soluble antioxidant metabolites at 300 uM by photochemiluminescence assay,Other,21805983.0,
519,711600,1,2,,103217472,370,Unspecified,,,,,Increase of median lifespan of L4 larvae of Caenorhabditis elegans harboring eat-2 (ad465) at 300 uM after 8 hrs,Other,21805983.0,
520,711601,1,2,,103217472,370,Unspecified,,,,,Increase of mean lifespan of L4 larvae of Caenorhabditis elegans harboring eat-2 (ad465) at 300 uM after 8 hrs,Other,21805983.0,
521,711604,1,2,,103217472,370,Active,,,,,Increase of frequency of pharyngeal pumping in Caenorhabditis elegans at 300 uM on 9th day of adulthood,Other,21805983.0,
522,711605,1,2,,103217472,370,Inactive,,,,,Reduction of frequency of pharyngeal pumping in Caenorhabditis elegans at 300 uM on 3rd to 9th day of adulthood,Other,21805983.0,
523,711609,1,2,,103217472,370,Active,,,,,Reduction of initial reproduction rate in Caenorhabditis elegans assessed as first egg deposition at 300 uM after 85 hrs,Other,21805983.0,
524,711612,1,2,,103217472,370,Active,,,,,Increase of body length of L4 larvae of Caenorhabditis elegans at 300 uM by microscopic analysis,Other,21805983.0,
525,711617,1,2,,103217472,370,Active,,,,,Increase of lifespan of L4 larvae of Caenorhabditis elegans at 300 uM in presence of heat killed bacteria,Other,21805983.0,
526,711619,1,2,,103217472,370,Unspecified,,,,,Increase of lifespan of L4 larvae of Caenorhabditis elegans assessed as lifespan increasing concentration after 8 hrs,Other,21805983.0,
527,711620,1,2,,103217472,370,Inactive,,,,,Increase of lifespan of L4 larvae of Caenorhabditis elegans at 300 uM after 8 hrs in presence of H2O2,Other,21805983.0,
528,711621,1,2,,103217472,370,Inactive,,,,,Increase of lifespan of L4 larvae of Caenorhabditis elegans at 300 uM at 35 degC after 8 hrs,Other,21805983.0,
529,711622,1,2,,103217472,370,Active,,,,,Increase of lifespan of L4 larvae of Caenorhabditis elegans after 8 hrs in presence of H2O2,Other,21805983.0,
530,711623,1,2,,103217472,370,Unspecified,,,,,Toxicity in L4 larvae of Caenorhabditis elegans at 800 uM after 8 hrs,Other,21805983.0,
531,711624,1,2,,103217472,370,Active,,,,,Increase of lifespan of L4 larvae of Caenorhabditis elegans at 35 degC after 8 hrs,Other,21805983.0,
532,711625,1,2,,103217472,370,Active,,,,,Increase of lifespan of L4 larvae of Caenorhabditis elegans after 8 hrs,Other,21805983.0,
533,715002,1,2,,103217472,370,Unspecified,,,,,Inhibition of mushroom tyrosinase using L-DOPA as substrate at 100 ug/ml after 10 mins,Other,22835872.0,
534,720516,2,1,,144204640,370,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
535,720516,2,1,,144209713,370,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
536,720532,1,1,,26747307,370,Active,420597.0,,3.1623,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
537,720532,1,1,,144204640,370,Inconclusive,420597.0,,25.1189,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
538,720533,1,1,,26747307,370,Active,,,11.2202,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
539,720533,1,1,,144204640,370,Inconclusive,,,35.4813,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
540,720552,2,1,,144204640,370,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
541,720552,2,1,,144209713,370,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
542,720579,2,1,,26747307,370,Inconclusive,222762.0,3707576.0,11.2202,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
543,720580,1,1,,26747307,370,Inconclusive,222762.0,3707576.0,28.1838,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
544,720634,2,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
545,720634,2,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
546,720635,2,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
547,720635,2,1,,144209713,370,Inconclusive,,,0.1951,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
548,720636,1,1,,17389871,370,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
549,720637,2,1,,144204640,370,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
550,720637,2,1,,144209713,370,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
551,720641,1,2,,92307197,370,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
552,720652,1,1,,17389871,370,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
553,720653,1,1,,17389871,370,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
554,720659,1,1,,17389871,370,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
555,720674,2,2,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
556,720674,2,2,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
557,720675,2,2,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
558,720675,2,2,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
559,720678,2,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
560,720678,2,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
561,720679,2,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
562,720679,2,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
563,720680,2,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
564,720680,2,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
565,720681,2,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
566,720681,2,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
567,720682,2,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
568,720682,2,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
569,720683,2,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
570,720683,2,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
571,720684,2,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
572,720684,2,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
573,720685,2,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
574,720685,2,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
575,720686,2,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
576,720686,2,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
577,720687,2,2,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
578,720687,2,2,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
579,720691,4,1,,144204640,370,Inactive,311348376.0,2908.0,6.74,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
580,720691,4,1,,144209713,370,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
581,720692,3,1,,144204640,370,Inconclusive,311348376.0,2908.0,0.5354,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
582,720692,3,1,,144209713,370,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
583,720693,3,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
584,720693,3,1,,144209713,370,Inconclusive,,,49.4339,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
585,720717,1,3,,92124939,370,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
586,720717,1,3,,92307197,370,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
587,720719,2,1,,144204640,370,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
588,720719,2,1,,144209713,370,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
589,720725,2,1,,144204640,370,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
590,720725,2,1,,144209713,370,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
591,725981,1,3,,103217472,370,Unspecified,,,300.0,IC50,Inhibition of CMG2 (40 to 217) C175A and R40C double mutant (unknown origin) interaction to full length PA E733C mutant expressed in Escherichia coli by FRET assay,Confirmatory,23394144.0,
592,730113,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity,Other,23332368.0,
593,730114,1,3,,103217472,370,Inconclusive,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 1 mM,Other,23332368.0,
594,730115,1,3,,103217472,370,Inconclusive,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 5.5 mM,Other,23332368.0,
595,730116,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 0.1 mM,Other,23332368.0,
596,732036,1,2,,103217472,370,Unspecified,,,,,Antimigratory activity against human U251 cells at 40 ug/ml after 8 hrs by wound closure assay,Other,23291333.0,
597,732037,1,2,,103217472,370,Unspecified,,,,,Antimigratory activity against human U251 cells at 30 ug/ml after 8 hrs by wound closure assay,Other,23291333.0,
598,732038,1,3,,103217472,370,Unspecified,,,,,Antimigratory activity against human U87 cells at 40 ug/ml after 8 hrs by wound closure assay,Other,23291333.0,
599,732039,1,3,,103217472,370,Unspecified,,,,,Antimigratory activity against human U87 cells at 30 ug/ml after 8 hrs by wound closure assay,Other,23291333.0,
600,732040,1,6,,103217472,370,Unspecified,14423632.0,6868.0,,,Inhibition of ADAM17 alpha-secretase activity in human UI87 cells using amyloid beta precursor protein as substrate at 40 ug/ml after 24 hrs by fluorimetric analysis,Other,23291333.0,
601,732041,1,6,,103217472,370,Unspecified,14423632.0,6868.0,,,Inhibition of ADAM17 alpha-secretase activity in human UI87 cells using amyloid beta precursor protein as substrate at 30 ug/ml after 24 hrs by fluorimetric analysis,Other,23291333.0,
602,732042,1,6,,103217472,370,Unspecified,14423632.0,6868.0,,,Inhibition of ADAM17 alpha-secretase activity in human UI87 cells using amyloid beta precursor protein as substrate at 20 ug/ml after 24 hrs by fluorimetric analysis,Other,23291333.0,
603,732043,1,3,,103217472,370,Unspecified,,,,,Cytotoxicity against rat fibroblast cells,Other,23291333.0,
604,732044,1,3,,103217472,370,Unspecified,,,,,Cytotoxicity against rat epithelial cells,Other,23291333.0,
605,732046,1,4,,103217472,370,Unspecified,,,,,Cytotoxicity against human KB cells,Other,23291333.0,
606,732049,1,2,,103217472,370,Active,,,4.75,IC50,Cytotoxicity against human imatinib-resistant K562 cells,Confirmatory,23291333.0,
607,732051,1,2,,103217472,370,Active,,,33.0,IC50,Cytotoxicity against human K562 cells,Confirmatory,23291333.0,
608,732052,1,2,,103217472,370,Unspecified,,,250.0,IC50,Cytotoxicity against mouse L929 cells,Confirmatory,23291333.0,
609,732053,1,3,,103217472,370,Active,,,40.0,IC50,Cytotoxicity against mouse WEHI231 cells,Confirmatory,23291333.0,
610,732054,1,2,,103217472,370,Unspecified,,,100.0,IC50,Cytotoxicity against human A549 cells,Confirmatory,23291333.0,
611,732055,1,3,,103217472,370,Active,,,10.0,IC50,Cytotoxicity against human Calu6 cells,Confirmatory,23291333.0,
612,732056,1,3,,103217472,370,Unspecified,,,282.0,IC50,Cytotoxicity against human P388D1 cells,Confirmatory,23291333.0,
613,732057,1,2,,103217472,370,Unspecified,,,358.0,IC50,Cytotoxicity against human HeLa cells,Confirmatory,23291333.0,
614,732058,1,3,,103217472,370,Unspecified,,,387.0,IC50,Cytotoxicity against human PLC/PRF/5 cells,Confirmatory,23291333.0,
615,732059,1,3,,103217472,370,Unspecified,,,364.0,IC50,Cytotoxicity against rat dRLh-84 cells,Confirmatory,23291333.0,
616,732060,1,3,,103217472,370,Unspecified,,,300.0,IC50,Cytotoxicity against human HL60 cells,Confirmatory,23291333.0,
617,732061,1,3,,103217472,370,Unspecified,,,317.0,IC50,Cytotoxicity against human HL60RG cells,Confirmatory,23291333.0,
618,732547,1,6,,103217472,370,Unspecified,6093533.0,18024.0,,,Activation of Nrf2 in mouse RAW264.7 cells assessed as upregulation of HO1 protein expression at 50 uM after 6 hrs by Western blotting analysis,Other,23294286.0,
619,732550,1,6,,103217472,370,Unspecified,6093533.0,18024.0,,,Activation of Nrf2 in mouse RAW264.7 cells assessed as upregulation of Hmox1 gene expression at 50 uM after 6 hrs by real-time PCR analysis relative to GAPDH mRNA expression,Other,23294286.0,
620,732559,1,2,,103217472,370,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells assessed as decreased cell viability at 50 uM after 6 hrs by MTT assay,Other,23294286.0,
621,736486,1,2,,103217472,370,Active,,,7.8,IC50,Antioxidant activity assessed as inhibition of ABTS radical formation for 15 mins by spectrophotometric analysis,Confirmatory,23357310.0,
622,736487,1,3,,103217472,370,Unspecified,,,,IC50,Antioxidant activity assessed as inhibition of DPPH radical formation measured every min for 45 mins by spectrophotometric analysis,Confirmatory,23357310.0,
623,743012,3,1,,144204640,370,Active,,,26.6032,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
624,743012,3,1,,144209713,370,Active,,,30.9185,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
625,743014,3,1,,144204640,370,Active,,,26.6032,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
626,743014,3,1,,144209713,370,Active,,,24.5594,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
627,743015,3,1,,144204640,370,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
628,743015,3,1,,144209713,370,Active,,,27.5561,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
629,743033,3,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
630,743033,3,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
631,743035,2,1,,144204640,370,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
632,743035,2,1,,144209713,370,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
633,743036,2,1,,144204640,370,Inconclusive,124375976.0,367.0,6.007000000000001,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
634,743036,2,1,,144209713,370,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
635,743040,3,1,,144204640,370,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
636,743040,3,1,,144209713,370,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
637,743041,3,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
638,743041,3,1,,144209713,370,Inconclusive,,,38.9241,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
639,743042,3,1,,144204640,370,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
640,743042,3,1,,144209713,370,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
641,743053,2,1,,144204640,370,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
642,743053,2,1,,144209713,370,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
643,743054,2,1,,144204640,370,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
644,743054,2,1,,144209713,370,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
645,743063,2,1,,144204640,370,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
646,743063,2,1,,144209713,370,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
647,743064,3,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
648,743064,3,1,,144209713,370,Active,,,54.9817,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
649,743065,3,1,,144204640,370,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
650,743065,3,1,,144209713,370,Inconclusive,399498506.0,24831.0,43.6735,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
651,743066,3,1,,144204640,370,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
652,743066,3,1,,144209713,370,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
653,743067,2,1,,144204640,370,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
654,743067,2,1,,144209713,370,Inconclusive,399498506.0,24831.0,54.9817,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
655,743069,2,1,,144204640,370,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
656,743069,2,1,,144209713,370,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
657,743074,2,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
658,743074,2,1,,144209713,370,Inconclusive,,,15.6324,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
659,743075,2,1,,144204640,370,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
660,743075,2,1,,144209713,370,Inactive,348019627.0,2099.0,34.9965,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
661,743077,2,1,,144204640,370,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
662,743077,2,1,,144209713,370,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
663,743078,2,1,,144204640,370,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
664,743078,2,1,,144209713,370,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
665,743079,3,1,,144204640,370,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
666,743079,3,1,,144209713,370,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
667,743080,3,1,,144204640,370,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
668,743080,3,1,,144209713,370,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
669,743081,3,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
670,743081,3,1,,144209713,370,Inconclusive,,,54.9817,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
671,743083,3,1,,144204640,370,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
672,743083,3,1,,144209713,370,Inconclusive,119597822.0,1588.0,69.2179,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
673,743084,3,1,,144204640,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
674,743084,3,1,,144209713,370,Active,,,49.0025,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
675,743085,3,1,,144204640,370,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
676,743085,3,1,,144209713,370,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
677,743086,3,1,,144204640,370,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
678,743086,3,1,,144209713,370,Inconclusive,,,61.6905,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
679,743091,2,1,,144204640,370,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
680,743091,2,1,,144209713,370,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
681,743094,3,1,,144204640,370,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
682,743094,3,1,,144209713,370,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
683,743122,2,1,,144204640,370,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
684,743122,2,1,,144209713,370,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
685,743139,2,1,,144204640,370,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
686,743139,2,1,,144209713,370,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
687,743140,2,1,,144204640,370,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
688,743140,2,1,,144209713,370,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
689,743191,3,1,,144209713,370,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
690,743191,3,1,,170465633,370,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
691,743194,3,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
692,743194,3,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
693,743199,2,1,,144209713,370,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
694,743199,2,1,,170465633,370,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
695,743202,4,1,,144209713,370,Inconclusive,20149576.0,4780.0,3.0918,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
696,743202,4,1,,170465633,370,Inconclusive,20149576.0,4780.0,5.9553,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
697,743203,3,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
698,743203,3,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
699,743209,3,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
700,743209,3,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
701,743210,4,1,,144209713,370,Inconclusive,4504517.0,3315.0,55.4657,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
702,743210,4,1,,170465633,370,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
703,743211,3,1,,144209713,370,Inconclusive,,,55.4657,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
704,743211,3,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
705,743212,3,1,,144209713,370,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
706,743212,3,1,,170465633,370,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
707,743213,3,1,,144209713,370,Inconclusive,,,0.0175,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
708,743213,3,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
709,743215,3,1,,144209713,370,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
710,743215,3,1,,170465633,370,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
711,743217,3,1,,144209713,370,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
712,743217,3,1,,170465633,370,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
713,743218,3,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
714,743218,3,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
715,743219,3,1,,144209713,370,Active,20149576.0,4780.0,6.61026,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
716,743219,3,1,,170465633,370,Inconclusive,20149576.0,4780.0,7.94146,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
717,743220,3,1,,144209713,370,Inconclusive,325495553.0,9971.0,62.2336,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
718,743220,3,1,,170465633,370,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
719,743221,3,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
720,743221,3,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
721,743222,3,1,,144209713,370,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
722,743222,3,1,,170465633,370,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
723,743223,3,1,,144209713,370,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
724,743223,3,1,,170465633,370,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
725,743224,3,1,,144209713,370,Inconclusive,,,55.4657,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
726,743224,3,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
727,743225,3,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
728,743225,3,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
729,743226,2,1,,144209713,370,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
730,743226,2,1,,170465633,370,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
731,743227,2,1,,144209713,370,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
732,743227,2,1,,170465633,370,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
733,743228,3,1,,144209713,370,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
734,743228,3,1,,170465633,370,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
735,743239,2,1,,144209713,370,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
736,743239,2,1,,170465633,370,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
737,743240,2,1,,144209713,370,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
738,743240,2,1,,170465633,370,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
739,743241,2,1,,144209713,370,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
740,743241,2,1,,170465633,370,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
741,743242,2,1,,144209713,370,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
742,743242,2,1,,170465633,370,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
743,743244,1,1,,144204640,370,Inconclusive,,,35.4813,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
744,743288,1,1,,17389871,370,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
745,743292,1,1,,17389871,370,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
746,763541,1,1,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as inhibition of ABTS free radical generation at 9 uM after 20 mins by UV spectrophotometric analysis relative to control,Other,23777828.0,
747,763542,1,1,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as inhibition of ABTS free radical generation at 17 uM after 20 mins by UV spectrophotometric analysis relative to control,Other,23777828.0,
748,768928,1,5,,103217472,370,Inactive,135807.0,2147.0,,,Inhibition of human thrombin amidolytic activity using D-Phe-Pip-Arg-pNA as substrate at 0.1 to 1000 uM preincubated for 10 mins followed by substrate addition measured every 12 secs for 10 mins by spectrophotometric analysis,Other,24610996.0,
749,781325,1,2,,103217472,370,Unspecified,,,,,pKa (acid-base dissociation constant) as determined by Liao ref: J Chem Info Model 2009,Other,24249037.0,
750,977599,1,1,,103217472,370,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
751,977602,1,2,,103217472,370,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
752,1055129,1,1,,103217472,370,Active,,,,,Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation at 1:0.1 to 1:2 protein to compound molar ratio after 20 hrs by transmission electron microscopic analysis,Other,24157371.0,
753,1055130,1,1,,103217472,370,Active,,,,,Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation at 1:0.1 to 1:2 protein to compound molar ratio up to 10 hrs by thioflavin T fluorescence assay,Other,24157371.0,
754,1055131,1,1,,103217472,370,Inactive,,,,,Effect on RCM-kappa-casein-induced cytotoxicity against rat PC12 cells at 1:0.1 to 1:0.5 protein to compound molar ratio after 48 hrs by MTT assay,Other,24157371.0,
755,1055132,1,1,,103217472,370,Unspecified,,,,,Effect on RCM-kappa-casein-induced cytotoxicity against rat PC12 cells assessed as increase in cell viability at 1:2 protein to compound molar ratio after 48 hrs by MTT assay relative to control,Other,24157371.0,
756,1055133,1,1,,103217472,370,Unspecified,,,,,Reduction in RCM-kappa-casein-induced cytotoxicity against rat PC12 cells after 48 hrs by MTT assay,Other,24157371.0,
757,1055134,1,1,,103217472,370,Unspecified,,,,,Cytotoxicity against rat PC12 cells assessed as cell viability at 5 uM after 48 hrs by MTT assay,Other,24157371.0,
758,1055135,1,1,,103217472,370,Active,,,,,Binding affinity to reduced carboxymethylated-kappa-casein (unknown origin) at 1:2 protein to compound molar ratio after 20 hrs by far-UV-CD spectroscopic analysis,Other,24157371.0,
759,1055136,1,1,,103217472,370,Active,,,,,"Inhibition of reduced carboxymethylated-kappa-casein (unknown origin) conversion to amyloid fibrils assessed as decrease in number of long, unbranched and mature amyloid fibrils at 1:2 protein to compound molar ratio after 1000 mins by transmission electron microscopic analysis",Other,24157371.0,
760,1055137,1,1,,103217472,370,Unspecified,,,,,Inhibition of reduced carboxymethylated-kappa-casein (unknown origin) conversion to amyloid fibrils at 1:0.1 protein to compound molar ratio after 1000 mins by thioflavin T fluorescence assay relative to control,Other,24157371.0,
761,1055138,1,1,,103217472,370,Unspecified,,,,,Inhibition of reduced carboxymethylated-kappa-casein (unknown origin) conversion to amyloid fibrils at 1:0.5 protein to compound molar ratio after 1000 mins by thioflavin T fluorescence assay relative to control,Other,24157371.0,
762,1055139,1,1,,103217472,370,Unspecified,,,,,Inhibition of reduced carboxymethylated-kappa-casein (unknown origin) conversion to amyloid fibrils at 1:1 protein to compound molar ratio after 1000 mins by thioflavin T fluorescence assay relative to control,Other,24157371.0,
763,1055140,1,1,,103217472,370,Unspecified,,,,IC50,Inhibition of reduced carboxymethylated-kappa-casein (unknown origin) conversion to amyloid fibrils after 1000 mins by thioflavin T fluorescence assay,Confirmatory,24157371.0,
764,1055141,1,1,,103217472,370,Unspecified,,,,,Inhibition of reduced carboxymethylated-kappa-casein (unknown origin) conversion to amyloid fibrils at 1:2 protein to compound molar ratio after 1000 mins by thioflavin T fluorescence assay relative to control,Other,24157371.0,
765,1064674,1,2,,103217472,370,Unspecified,,,,,Antioxidant activity of the compound assessed as inhibition of ABTS radicals after 20 mins by spectrophotometric analysis,Other,24411196.0,
766,1064675,1,2,,103217472,370,Unspecified,,,,,Antioxidant activity of the compound assessed as inhibition of ABTS radicals at 9 uM after 20 mins by spectrophotometric analysis,Other,24411196.0,
767,1064676,1,2,,103217472,370,Unspecified,,,,,Antioxidant activity of the compound assessed as inhibition of ABTS radicals at 17 uM after 20 mins by spectrophotometric analysis,Other,24411196.0,
768,1064677,1,2,,103217472,370,Unspecified,,,,,Antioxidant activity of the compound assessed as inhibition of ABTS radicals at 33 uM after 20 mins by spectrophotometric analysis,Other,24411196.0,
769,1082335,1,1,,103217472,370,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
770,1082336,1,1,,103217472,370,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
771,1082337,1,1,,103217472,370,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
772,1082338,1,1,,103217472,370,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
773,1082339,1,1,,103217472,370,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
774,1082340,1,1,,103217472,370,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
775,1082341,1,1,,103217472,370,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
776,1082342,1,1,,103217472,370,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
777,1082343,1,1,,103217472,370,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
778,1082344,1,1,,103217472,370,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
779,1082345,1,1,,103217472,370,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
780,1082346,1,1,,103217472,370,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
781,1082349,1,1,,103217472,370,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
782,1082350,1,1,,103217472,370,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
783,1082351,1,1,,103217472,370,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
784,1082352,1,1,,103217472,370,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
785,1082357,1,1,,103217472,370,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
786,1082358,1,1,,103217472,370,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
787,1082359,1,1,,103217472,370,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
788,1082360,1,1,,103217472,370,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
789,1083149,1,1,,103217472,370,Unspecified,,,,,Nematotoxic activity against freshly hatched Meloidogyne incognita J2 (root-knot nematode) isolated from tomato roots assessed as induction of nematode paralysis measured 24 hr after immersion in compound test solutions,Other,23136941.0,
790,1083154,1,1,,103217472,370,Unspecified,,,,,Antifungal activity against Diplodia seriata BoF98-1 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
791,1083155,1,1,,103217472,370,Unspecified,,,,,Antifungal activity against Diplodia seriata BoF99-1 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
792,1083156,1,1,,103217472,370,Unspecified,,,,,Antifungal activity against Diplodia seriata LAT28 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
793,1083157,1,1,,103217472,370,Unspecified,,,,,Antifungal activity against Lasiodiplodia theobromae CBS116460 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
794,1083158,1,1,,103217472,370,Unspecified,,,,,Antifungal activity against Diplodia seriata PLU03 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
795,1083159,1,1,,103217472,370,Unspecified,,,,,Antifungal activity against Diplodia mutila BRA08 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
796,1083160,1,1,,103217472,370,Unspecified,,,,,Antifungal activity against Neofusicoccum luteum CBS110299 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
797,1083161,1,1,,103217472,370,Unspecified,,,,,Antifungal activity against Neofusicoccum parvum PER20 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
798,1083162,1,1,,103217472,370,Unspecified,,,,,Antifungal activity against Neofusicoccum parvum Bp0014 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
799,1083163,1,1,,103217472,370,Unspecified,,,,,Antifungal activity against Botryosphaeria dothidea OGE14 assessed as growth inhibition measured after 1 to 10 days relative to control,Other,23145924.0,
800,1083171,1,1,,103217472,370,Inactive,,,,,Antifungal activity against Togninia minima SO21 assessed as susceptibility at 500 uM measured after 1 to 10 days,Other,23145924.0,
801,1083844,1,2,,103217472,370,Unspecified,,,112.0,IC50,Inhibition of alpha-glucosidase (unknown origin) using PNPG as substrate assessed as p-nitrophenol release from substrate after 30 min,Confirmatory,,
802,1085476,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 10 uM by spectrophotometric analysis,Other,,
803,1086143,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 1 uM after 20 min by spectrophotometric analysis,Other,,
804,1087143,1,4,,103217472,370,Unspecified,126716.0,,,,Inhibition of baker's yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate by spectrophotometry,Other,,
805,1087332,1,2,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH scavenging activity after 2 hr by spectrophotometry,Other,,
806,1087333,1,2,,103217472,370,Unspecified,,,,,Antioxidant activity in phosphate buffer at pH 6.6 assessed as reducing power measuring conversion of potassium ferricyanide to ferrous form after 10 min by spectrophotometry,Other,,
807,1100608,1,1,,103217472,370,Unspecified,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 5 umol/disk by paper disk method,Other,84.0,
808,1100609,1,1,,103217472,370,Inactive,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 0.5 umol/disk by paper disk method,Other,84.0,
809,1101855,3,1,,103217472,370,Unspecified,,,,,Antifungal activity against Saccharomyces cerevisiae ATCC 7754 after 48 hr by microdilution method,Other,12083872.0,
810,1105370,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 5 ug/mL after 20 min by UV-Vis spectrophotometric analysis,Other,23229055.0,
811,1105371,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 4 ug/mL after 20 min by UV-Vis spectrophotometric analysis,Other,23229055.0,
812,1105372,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 2 ug/mL after 20 min by UV-Vis spectrophotometric analysis,Other,23229055.0,
813,1105373,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 3 ug/mL after 20 min by UV-Vis spectrophotometric analysis,Other,23229055.0,
814,1105374,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 1 ug/mL after 20 min by UV-Vis spectrophotometric analysis,Other,23229055.0,
815,1105375,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 0.6 ug/mL after 20 min by UV-Vis spectrophotometric analysis,Other,23229055.0,
816,1105376,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 0.8 ug/mL after 20 min by UV-Vis spectrophotometric analysis,Other,23229055.0,
817,1105377,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 0.4 ug/mL after 20 min by UV-Vis spectrophotometric analysis,Other,23229055.0,
818,1105378,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 0.2 ug/mL after 20 min by UV-Vis spectrophotometric analysis,Other,23229055.0,
819,1105379,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 0.1 ug/mL after 20 min by UV-Vis spectrophotometric analysis,Other,23229055.0,
820,1105397,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity after 20 min by UV-Vis spectrophotometric analysis,Other,23229055.0,
821,1110806,1,1,,103217472,370,Active,,,41.7,IC50,Inhibition of xanthine oxidase assessed as conversion of xanthine to uric acid incubated for 3 min,Confirmatory,15652581.0,
822,1110807,1,1,,103217472,370,Unspecified,,,,,Antimicrobial activity against Candida albicans at 100 ug after 24 hr by disk diffusion method,Other,15652581.0,
823,1110808,1,2,,103217472,370,Unspecified,,,,,Antimicrobial activity against Corynebacterium accolens at 100 ug after 24 hr by disk diffusion method,Other,15652581.0,
824,1110809,1,1,,103217472,370,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus at 100 ug after 24 hr by disk diffusion method,Other,15652581.0,
825,1110810,1,1,,103217472,370,Unspecified,,,,,Antimicrobial activity against Pectobacterium carotovorum at 100 ug after 24 hr by disk diffusion method,Other,15652581.0,
826,1116435,1,3,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as inhibition of DPPH free radicals at 400 uM after 30 min by microplate reader analysis relative to control,Other,,
827,1117298,1,2,,170465633,370,Inactive,,,28.1838,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
828,1117304,1,2,,170465633,370,Unspecified,,,39.8107,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
829,1117305,1,2,,170465633,370,Inactive,,,22.3872,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
830,1117310,1,1,,170465633,370,Inactive,,,28.1838,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
831,1117312,1,1,,170465633,370,Inactive,,,22.3872,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
832,1117314,1,1,,170465633,370,Inactive,,,39.8107,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
833,1117326,1,1,,170465633,370,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
834,1117329,1,1,,170465633,370,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
835,1117336,1,1,,170465633,370,Inactive,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
836,1117340,1,1,,170465633,370,Inactive,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
837,1117341,1,1,,170465633,370,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
838,1117342,1,1,,170465633,370,Inactive,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
839,1117343,1,1,,170465633,370,Inactive,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
840,1117346,1,1,,170465633,370,Inactive,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
841,1121530,1,1,,103217472,370,Active,,,,,Antioxidant activity assessed as reduction of Fe(3)-TPTZ to Fe(2)-TPTZ complex after 5 mins by FRAP assay,Other,,
842,1126662,1,2,,103217472,370,Active,,,5.34,EC50,Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometry,Confirmatory,24681984.0,
843,1128675,1,2,,103217472,370,Unspecified,,,163.1,IC50,Cytotoxicity against mouse TA3/Ha cells after 48 hrs by neutral red assay,Confirmatory,24568614.0,
844,1128676,1,2,,103217472,370,Unspecified,,,160.2,IC50,Cytotoxicity against mouse multidrug-resistant TA3-MTX-R cells after 48 hrs by neutral red assay,Confirmatory,24568614.0,
845,1128677,1,2,,103217472,370,Unspecified,,,200.0,IC50,Cytotoxicity against human CCRF-CEM cells after 48 hrs by neutral red assay,Confirmatory,24568614.0,
846,1128678,1,2,,103217472,370,Unspecified,,,200.0,IC50,Cytotoxicity against mouse MM3MG cells after 48 hrs by neutral red assay,Confirmatory,24568614.0,
847,1129833,1,3,,103217472,370,Unspecified,123867998.0,,,,Inhibition of Influenza A virus (A/RI/5+/1957(H2N2)) recombinant neuraminidase using MUNANA as substrate at 100 uM after 30 mins,Other,24613627.0,
848,1129834,1,3,,103217472,370,Inconclusive,123867998.0,,,IC50,Inhibition of Influenza A virus (A/RI/5+/1957(H2N2)) recombinant neuraminidase using MUNANA as substrate after 30 mins,Confirmatory,24613627.0,
849,1129835,1,1,,103217472,370,Inactive,,,,,Inhibition of His-6-tagged Coxsackievirus B3 3C protease expressed in Escherichia coli BL21(DE3) using Asp-Glu-EDANS-(5-((2-aminoethyl)amino)naphthalene-1-sulfonic acid)-MSAIFQGPISK-DABCYL (4-((4-(dimethylamino)phenyl)azo)benzoic acid) as peptide substrate at 100 uM by fluorescence-based absorbance assay,Other,24613627.0,
850,1130099,1,3,,103217472,370,Unspecified,117293.0,1588.0,,,Inhibition of human aromatase using androstenedione as substrate assessed as remaining estrone level at 10 uM after 30 mins by LC-MS/MS analysis relative to control,Other,24630560.0,
851,1158457,1,3,,103217472,370,Inactive,121763.0,25139.0,,,Enhancement of GLUT4 translocation in rat L6 cells expressing pIRAP-mOrange cDNAs at 10 uM after 10 mins by fluorescence assay relative to control,Other,24894556.0,
852,1159509,1,1,,144209713,370,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
853,1159509,1,1,,170465633,370,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
854,1159515,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
855,1159515,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
856,1159516,1,1,,144209713,370,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
857,1159516,1,1,,170465633,370,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
858,1159517,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
859,1159517,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
860,1159518,1,1,,144209713,370,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
861,1159518,1,1,,170465633,370,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
862,1159519,1,1,,144209713,370,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
863,1159519,1,1,,170465633,370,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
864,1159520,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
865,1159520,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
866,1159521,1,1,,144209713,370,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
867,1159521,1,1,,170465633,370,Inactive,15928672.0,19885.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
868,1159523,1,1,,144209713,370,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
869,1159523,1,1,,170465633,370,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
870,1159524,1,1,,26747307,370,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
871,1159525,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
872,1159525,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
873,1159526,1,1,,144209713,370,Inconclusive,119627033.0,3725.0,62.2336,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
874,1159526,1,1,,170465633,370,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
875,1159527,1,1,,144209713,370,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
876,1159527,1,1,,170465633,370,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
877,1159528,1,1,,144209713,370,Active,119627033.0,3725.0,55.4657,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
878,1159528,1,1,,170465633,370,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
879,1159529,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
880,1159529,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
881,1159531,1,1,,144209713,370,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
882,1159531,1,1,,170465633,370,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
883,1159550,3,1,,252401411,370,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
884,1159551,1,1,,144209713,370,Inconclusive,,,54.9817,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
885,1159551,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
886,1159552,1,1,,144209713,370,Inactive,325495463.0,5914.0,77.6637,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
887,1159552,1,1,,170465633,370,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
888,1159553,2,1,,144209713,370,Inconclusive,325495463.0,5914.0,77.6637,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
889,1159553,2,1,,170465633,370,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
890,1159555,1,1,,144209713,370,Inconclusive,325495463.0,5914.0,24.5594,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
891,1159555,1,1,,170465633,370,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
892,1159580,2,1,,268734426,370,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
893,1159607,2,1,,312995960,370,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
894,1159614,1,2,,170465633,370,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
895,1161573,1,1,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as ABTS free radical scavenging activity measured as trolox equivalent after 1 hr by spectrophotometry,Other,25156301.0,
896,1161574,1,2,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity measured as trolox equivalent after 30 mins by spectrophotometry,Other,25156301.0,
897,1161575,1,1,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as total polyphenolics measured as gallic acid equivalent after 30 mins by Folin-Ciocalteu assay,Other,25156301.0,
898,1167300,1,2,,103217472,370,Active,,,11.0,IC50,Antioxidant activity assessed as DPPH radical scavenging activity incubated at room temperature for 20 mins by UV-visible spectrophotometry,Confirmatory,25278230.0,
899,1176782,1,2,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by UV-spectrophotometry,Other,25517504.0,
900,1186044,1,1,,103217472,370,Unspecified,,,,,Cytotoxicity against human HL60 cells assessed as cell survival at 50 uM after 72 hrs by CCK8 assay,Other,25074815.0,
901,1186051,1,1,,103217472,370,Unspecified,,,,,Retention time of the compound by UPLC analysis,Other,25074815.0,
902,1187066,1,1,,103217472,370,Unspecified,,,,,Inhibition of insulin fibril formation (unknown origin) assessed as turbidity at 1:5 insulin to compound ratio at pH2 up to 12 hrs by UV/vis spectrometry,Other,25105923.0,
903,1187067,1,1,,103217472,370,Active,,,,,Inhibition of insulin fibril formation (unknown origin) assessed as turbidity at 1:10 insulin to compound ratio at pH2 up to 12 hrs by UV/vis spectrometry,Other,25105923.0,
904,1187068,1,1,,103217472,370,Unspecified,,,,,Inhibition of insulin fibril formation (unknown origin) assessed as turbidity at 1:50 insulin to compound ratio at pH2 up to 12 hrs by UV/vis spectrometry,Other,25105923.0,
905,1187069,1,1,,103217472,370,Unspecified,,,,,Inhibition of insulin fibril formation (unknown origin) assessed as turbidity at pH2 up to 12 hrs by UV/vis spectrometry,Other,25105923.0,
906,1187070,1,1,,103217472,370,Active,,,,,Inhibition of insulin fibril formation (unknown origin) assessed as turbidity at 1:20 insulin to compound ratio at pH2 up to 12 hrs by atomic force microscopy,Other,25105923.0,
907,1187071,1,1,,103217472,370,Active,,,,,Inhibition of insulin fibril formation (unknown origin) assessed as decrease in ThT fluorescence at 1:5 insulin to compound ratio at pH2 up to 12 hrs by ThT binding assay,Other,25105923.0,
908,1187072,1,1,,103217472,370,Active,,,,,Inhibition of insulin fibril formation (unknown origin) assessed as decrease in ThT fluorescence at 1:50 insulin to compound ratio at pH2 up to 12 hrs by ThT binding assay,Other,25105923.0,
909,1187073,1,1,,103217472,370,Active,,,,,Inhibition of insulin fibril formation (unknown origin) assessed as secondary structural changes at 1:5 insulin to compound ratio at pH2 up to 12 hrs by Far-UV CD spectra,Other,25105923.0,
910,1187074,1,1,,103217472,370,Active,,,,,Inhibition of insulin fibril formation (unknown origin) assessed as secondary structural changes at 1:5 insulin to compound ratio at pH2 up to 12 hrs by FT-IR technique,Other,25105923.0,
911,1191655,1,1,,103217472,370,Unspecified,,,60000.0,IC50,Antioxidant activity assessed as ABTS scavenging activity after 6 mins by spectrophotometry,Confirmatory,25638040.0,
912,1191657,1,1,,103217472,370,Unspecified,,,100000.0,IC50,Antioxidant activity assessed as DMPD scavenging activity after 15 mins by spectrophotometry,Confirmatory,25638040.0,
913,1197620,1,1,,103217472,370,Unspecified,,,50.0,EC50,Antiviral activity against HIV1 3B infected in human CEM cells assessed as reduction in virus-induced cytopathicity after 4 to 5 days by microscopy based syncytium cell formation assay,Confirmatory,25617695.0,
914,1197621,1,1,,103217472,370,Unspecified,,,50.0,EC50,Antiviral activity against HIV2 ROD infected in human CEM cells assessed as reduction in virus-induced cytopathicity after 4 to 5 days by microscopy based syncytium cell formation assay,Confirmatory,25617695.0,
915,1197622,1,1,,103217472,370,Unspecified,,,250.0,CC50,Cytotoxicity against human CEM cells assessed as inhibition of cell proliferation,Confirmatory,25617695.0,
916,1197637,1,1,,103217472,370,Inactive,,,,,Antiviral activity against vaccinia virus,Other,25617695.0,
917,1197638,1,1,,103217472,370,Inactive,,,,,Antiviral activity against vesicular stomatitis virus,Other,25617695.0,
918,1197639,1,1,,103217472,370,Inactive,,,,,Antiviral activity against human coxsackievirus B4,Other,25617695.0,
919,1197640,1,1,,103217472,370,Inactive,,,,,Antiviral activity against RSV,Other,25617695.0,
920,1197641,1,1,,103217472,370,Inactive,,,,,Antiviral activity against human parainfluenza virus 3,Other,25617695.0,
921,1197642,1,1,,103217472,370,Inactive,,,,,Antiviral activity against reovirus,Other,25617695.0,
922,1197643,1,1,,103217472,370,Inactive,,,,,Antiviral activity against sindbis virus,Other,25617695.0,
923,1197644,1,1,,103217472,370,Inactive,,,,,Antiviral activity against influenza A virus H3N2,Other,25617695.0,
924,1197645,1,1,,103217472,370,Inactive,,,,,Antiviral activity against influenza A virus (H1N1),Other,25617695.0,
925,1197646,1,1,,103217472,370,Inactive,,,,,Antiviral activity against punta toro virus,Other,25617695.0,
926,1197647,1,1,,103217472,370,Inactive,,,,,Antiviral activity against feline coronavirus,Other,25617695.0,
927,1197648,1,1,,103217472,370,Inactive,,,,,Antiviral activity against feline herpesvirus,Other,25617695.0,
928,1197649,1,1,,103217472,370,Inactive,,,,,Antiviral activity against chikungunya virus,Other,25617695.0,
929,1204902,1,2,,103217472,370,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity measured as decoloration of a MeOH solution after 10 mins by spectrophotometry,Other,25611215.0,
930,1224834,3,1,,144209713,370,Active,,,61.6905,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
931,1224834,3,1,,170465633,370,Inconclusive,,,23.7101,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
932,1224835,1,1,,144209713,370,Inconclusive,160794.0,,71.6753,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
933,1224835,1,1,,170465633,370,Inconclusive,160794.0,,30.9008,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
934,1224836,1,1,,144209713,370,Inconclusive,,,69.2179,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
935,1224836,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
936,1224837,1,1,,144209713,370,Inconclusive,,,54.9817,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
937,1224837,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
938,1224838,1,1,,144209713,370,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
939,1224838,1,1,,170465633,370,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
940,1224839,1,1,,144209713,370,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
941,1224839,1,1,,170465633,370,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
942,1224840,3,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
943,1224840,3,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
944,1224841,3,1,,144209713,370,Active,325495545.0,2101.0,30.9185,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
945,1224841,3,1,,170465633,370,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
946,1224842,3,1,,144209713,370,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
947,1224842,3,1,,170465633,370,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
948,1224843,1,1,,144209713,370,Inconclusive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
949,1224843,1,1,,170465633,370,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
950,1224844,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
951,1224844,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
952,1224845,1,1,,144209713,370,Inconclusive,344243002.0,100757539.0,45.4268,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
953,1224845,1,1,,170465633,370,Inconclusive,344243002.0,100757539.0,24.6554,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
954,1224846,1,1,,144209713,370,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
955,1224846,1,1,,170465633,370,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
956,1224847,1,1,,144209713,370,Inconclusive,,,114.10700000000001,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
957,1224847,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
958,1224848,3,1,,144209713,370,Inconclusive,325495545.0,2101.0,38.9241,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
959,1224848,3,1,,170465633,370,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
960,1224849,3,1,,144209713,370,Inactive,325495545.0,2101.0,38.9241,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
961,1224849,3,1,,170465633,370,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
962,1224857,2,1,,170465633,370,Inconclusive,,,31.6228,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
963,1224859,2,1,,170465633,370,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
964,1224863,1,1,,316919640,370,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
965,1224867,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
966,1224867,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
967,1224868,1,1,,144209713,370,Inconclusive,,,49.4339,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
968,1224868,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
969,1224869,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
970,1224869,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
971,1224870,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
972,1224870,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
973,1224871,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
974,1224871,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
975,1224872,1,1,,144209713,370,Inconclusive,,,49.4339,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
976,1224872,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
977,1224873,1,1,,144209713,370,Inconclusive,,,39.2667,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
978,1224873,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
979,1224874,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
980,1224874,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
981,1224875,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
982,1224875,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
983,1224876,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
984,1224876,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
985,1224877,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
986,1224877,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
987,1224878,1,1,,144209713,370,Inactive,,,27.7987,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
988,1224878,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
989,1224879,1,1,,144209713,370,Inactive,,,39.2667,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
990,1224879,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
991,1224880,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
992,1224880,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
993,1224881,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
994,1224881,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
995,1224882,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
996,1224882,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
997,1224883,1,1,,144209713,370,Inactive,,,39.2667,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
998,1224883,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
999,1224884,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1000,1224884,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1001,1224885,1,1,,144209713,370,Inconclusive,,,44.058,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1002,1224885,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1003,1224886,1,1,,144209713,370,Inconclusive,,,55.4657,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1004,1224886,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1005,1224887,1,1,,144209713,370,Inconclusive,,,49.4339,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1006,1224887,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1007,1224888,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1008,1224888,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1009,1224889,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1010,1224889,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1011,1224890,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1012,1224890,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1013,1224892,1,1,,144209713,370,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1014,1224892,1,1,,170465633,370,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1015,1224893,1,1,,144209713,370,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1016,1224893,1,1,,170465633,370,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1017,1224894,1,1,,144209713,370,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1018,1224894,1,1,,170465633,370,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1019,1224895,1,1,,144209713,370,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1020,1224895,1,1,,170465633,370,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1021,1224896,1,1,,144209713,370,Inconclusive,344243002.0,100757539.0,25.5454,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1022,1224896,1,1,,170465633,370,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1023,1228617,1,1,,103217472,370,Active,,,15.66,IC50,Antioxidant activity assessed as hydroxy radical-scavenging activity,Confirmatory,25918997.0,
1024,1228618,1,1,,103217472,370,Active,,,7.23,IC50,Antioxidant activity assessed as DPPH radical-scavenging activity incubated for 30 mins by spectrophotometry,Confirmatory,25918997.0,
1025,1236191,1,1,,103217472,370,Active,1730137.0,2529.0,0.06,IC50,Inhibition of FucT-7 (unknown origin),Confirmatory,,
1026,1236192,1,1,,103217472,370,Active,226694189.0,2526.0,14.0,IC50,Inhibition of FucT-4 (unknown origin),Confirmatory,,
1027,1236193,1,1,,103217472,370,Active,,,19.0,IC50,Inhibition of sialyltransferase (unknown origin),Confirmatory,,
1028,1239713,1,1,,103217472,370,Inactive,,,,,Anti-platelet activity in rat platelet rich plasma assessed as inhibition of ADP and calcium-induced platelet aggregation at 100 uM pre-incubated at 37 degC for 10 mins and measured 30 mins after ADP and calcium addition,Other,26096681.0,
1029,1256912,1,1,,103217472,370,Unspecified,21903432.0,3417.0,,,Inhibition of human IDH1 R132H mutant expressed in IPTG-induced Escherichia coli BL21 cells assessed as oxidation of NADPH to NADP+ after 5 mins by spectrophotometry,Other,26508549.0,
1030,1256913,1,1,,103217472,370,Unspecified,21903432.0,3417.0,,,Inhibition of human IDH1 expressed in IPTG-induced Escherichia coli BL21 cells assessed as reduction of NADP+ to NADPH after 5 mins by spectrophotometry,Other,26508549.0,
1031,1259241,1,1,,144209713,370,Inconclusive,,,54.9817,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1032,1259241,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1033,1259242,1,1,,144209713,370,Inconclusive,,,49.0025,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1034,1259242,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1035,1259243,1,1,,144209713,370,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1036,1259243,1,1,,170465633,370,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1037,1259244,1,1,,144209713,370,Inconclusive,348019627.0,2099.0,49.0025,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1038,1259244,1,1,,170465633,370,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1039,1259247,1,1,,144209713,370,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1040,1259247,1,1,,170465633,370,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1041,1259248,1,1,,144209713,370,Inconclusive,348019627.0,2099.0,49.0025,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1042,1259248,1,1,,170465633,370,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1043,1259310,1,1,,321949543,370,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1044,1259310,1,1,,333493823,370,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1045,1259310,1,1,,333494112,370,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1046,1259344,1,1,,144204640,370,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1047,1259355,1,1,,144204640,370,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
1048,1259356,1,1,,144204640,370,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
1049,1259364,1,1,,144209713,370,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1050,1259364,1,1,,170465633,370,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1051,1259365,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1052,1259365,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1053,1259366,1,1,,144209713,370,Active,,,61.6905,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1054,1259366,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1055,1259367,1,1,,144209713,370,Inconclusive,,,49.0025,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1056,1259367,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1057,1259368,1,1,,144209713,370,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1058,1259368,1,1,,170465633,370,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1059,1259369,1,1,,144209713,370,Active,109731339.0,2737.0,27.5561,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1060,1259369,1,1,,170465633,370,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1061,1259377,1,1,,144209713,370,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1062,1259377,1,1,,170465633,370,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1063,1259378,1,1,,144209713,370,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1064,1259378,1,1,,170465633,370,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1065,1259379,1,1,,144209713,370,Active,,,54.9817,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1066,1259379,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1067,1259380,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1068,1259380,1,1,,170465633,370,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1069,1259381,1,1,,144209713,370,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1070,1259381,1,1,,170465633,370,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1071,1259382,1,1,,144209713,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1072,1259382,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1073,1259383,1,1,,144209713,370,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1074,1259383,1,1,,170465633,370,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1075,1259384,1,1,,144209713,370,Inconclusive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1076,1259384,1,1,,170465633,370,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1077,1259385,1,1,,144209713,370,Inconclusive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1078,1259385,1,1,,170465633,370,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1079,1259386,1,1,,144209713,370,Active,,,54.9817,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1080,1259386,1,1,,170465633,370,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1081,1259387,1,1,,144209713,370,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1082,1259387,1,1,,170465633,370,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1083,1259388,1,1,,144209713,370,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1084,1259388,1,1,,170465633,370,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1085,1259389,1,1,,124636521,370,Active,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1086,1259390,1,1,,144209713,370,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1087,1259390,1,1,,170465633,370,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1088,1259391,1,1,,144209713,370,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1089,1259391,1,1,,170465633,370,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1090,1259392,1,1,,144209713,370,Inconclusive,109731339.0,2737.0,21.2676,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1091,1259392,1,1,,170465633,370,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1092,1259393,1,1,,144209713,370,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1093,1259393,1,1,,170465633,370,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1094,1259394,1,1,,144209713,370,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1095,1259394,1,1,,170465633,370,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1096,1259395,1,1,,144209713,370,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1097,1259395,1,1,,170465633,370,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1098,1259396,1,1,,144209713,370,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1099,1259396,1,1,,170465633,370,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1100,1259400,1,1,,170465633,370,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
1101,1259401,1,1,,144209713,370,Inconclusive,325495545.0,2101.0,53.4218,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1102,1259401,1,1,,170465633,370,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1103,1259402,1,1,,144209713,370,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1104,1259402,1,1,,170465633,370,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1105,1259403,1,1,,144209713,370,Inconclusive,325495545.0,2101.0,40.4469,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1106,1259403,1,1,,170465633,370,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1107,1259404,1,1,,144209713,370,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1108,1259404,1,1,,170465633,370,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1109,1259407,1,1,,363903473,370,Inactive,,,,,CCRIS mutagenicity studies,Other,,
1110,1259408,1,1,,363895496,370,Active,,,,,GENE-TOX mutagenicity studies,Other,,
1111,1259409,1,1,,363903473,370,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
1112,1259416,1,2,,340085698,370,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1113,1259421,1,1,,340085698,370,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1114,1259423,1,2,,354910754,370,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
